Photokeratitis, right eye
ICD-10 H16.131 is a billable code used to indicate a diagnosis of photokeratitis, right eye.
Photokeratitis, commonly referred to as 'snow blindness,' is an acute condition resulting from excessive exposure to ultraviolet (UV) light, primarily affecting the cornea of the right eye. Clinically, it presents with symptoms such as severe pain, redness, tearing, and blurred vision, often occurring within hours of exposure. The cornea, which is the transparent front part of the eye, becomes inflamed and damaged due to the UV radiation, leading to epithelial cell death and subsequent symptoms. The condition can progress rapidly, and if left untreated, may result in complications such as corneal scarring or infection. Diagnosis is typically made through patient history and clinical examination, where signs of corneal edema and punctate keratitis may be observed. Treatment involves symptomatic relief with analgesics, topical lubricants, and sometimes corticosteroids to reduce inflammation. Protective eyewear is crucial in preventing recurrence. Understanding the anatomy involved, particularly the cornea and its response to UV exposure, is essential for effective management and prevention of this condition.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H16.131 specifically covers photokeratitis affecting the right eye, which is characterized by corneal inflammation due to UV exposure. It does not include other forms of keratitis or ocular surface disorders.
H16.131 should be used when the diagnosis is confirmed as photokeratitis of the right eye, particularly when symptoms and clinical findings align with this specific condition, differentiating it from other keratitis types.
Documentation should include a detailed patient history of UV exposure, clinical examination findings indicating corneal damage, and any treatment provided. This may include visual acuity tests and assessments of corneal integrity.
